Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by abrdn plc

abrdn plc increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 170.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 259,894 shares of the medical equipment provider's stock after purchasing an additional 163,742 shares during the quarter. abrdn plc owned approximately 0.07% of Intuitive Surgical worth $87,678,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the business. Liberty Capital Management Inc. lifted its holdings in Intuitive Surgical by 3.8% in the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider's stock worth $275,000 after buying an additional 30 shares during the period. Miracle Mile Advisors LLC lifted its holdings in shares of Intuitive Surgical by 2.3% during the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider's stock valued at $485,000 after purchasing an additional 32 shares during the last quarter. Ausdal Financial Partners Inc. lifted its holdings in shares of Intuitive Surgical by 1.5% during the fourth quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider's stock valued at $739,000 after purchasing an additional 33 shares during the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 10.7% during the fourth quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider's stock valued at $115,000 after purchasing an additional 33 shares during the last quarter. Finally, Modera Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 2.0% during the third quarter. Modera Wealth Management LLC now owns 1,715 shares of the medical equipment provider's stock valued at $501,000 after purchasing an additional 34 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 1.7 %

NASDAQ:ISRG traded down $6.29 during trading hours on Friday, reaching $366.34. The company had a trading volume of 3,975,892 shares, compared to its average volume of 1,399,392. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The firm has a market cap of $129.85 billion, a price-to-earnings ratio of 66.13, a PEG ratio of 5.69 and a beta of 1.36. The firm's 50 day moving average price is $386.84 and its 200-day moving average price is $343.86.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts' consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 13.27%. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the firm posted $1.00 EPS. The firm's revenue was up 11.5% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Mark Brosius sold 196 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares of the company's stock, valued at approximately $736,800. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, SVP Mark Brosius sold 196 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares of the company's stock, valued at approximately $736,800. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the sale, the executive vice president now directly owns 5,507 shares of the company's stock, valued at approximately $2,168,656.60. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock valued at $95,927,097 in the last 90 days. Company insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Piper Sandler lifted their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an "overweight" rating in a report on Friday. Robert W. Baird lowered their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an "outperform" rating for the company in a report on Friday. Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an "outperform" rating in a report on Wednesday, January 24th. Citigroup lifted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a "buy" rating in a report on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $396.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.